ISATUXIMAB PLUS POMALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: ICARIA-MM SUBGROUP ANALYSIS
| Autor: | Sara Bringhen, A. Neylon, P. Corradini, S. Delimpasi, M. Beksac, G. Mikala, H.V. Velde, Argiris Symeonidis, Ali Ünal, S.L. Guennec, P. Moreau, Ivan Spicka, F. Campana, Z. Gulbas, P.G. Richardson, M.E.Z. Capra |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Isatuximab
Oncology medicine.medical_specialty business.industry lcsh:RC633-647.5 Soft tissue Subgroup analysis Hematology lcsh:Diseases of the blood and blood-forming organs medicine.disease Pomalidomide Internal medicine Relapsed refractory Immunology and Allergy Medicine In patient business Multiple myeloma Dexamethasone medicine.drug |
| Zdroj: | Hematology, Transfusion and Cell Therapy, Vol 42, Iss, Pp 263-264 (2020) |
| ISSN: | 2531-1379 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|